Edition:
India

Miyoung Kim

Sinovac's COVID-19 vaccine induces quick immune response - study

18 Nov 2020

SINGAPORE/BEIJING Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday. | Video

Sinovac's COVID-19 vaccine induces quick immune response - study

18 Nov 2020

SINGAPORE/BEIJING, Nov 18 Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.

Samsung's Lee: tainted titan who built a global tech giant

25 Oct 2020

SEOUL In February 1993, five years after taking over from his father at South Korea's Samsung Group, 51-year-old Lee Kun-hee was frustrated that he wasn't making his mark. | Video

Samsung's Lee: tainted titan who built a global tech giant

25 Oct 2020

SEOUL In February 1993, five years after taking over from his father at South Korea's Samsung Group, 51-year-old Lee Kun-hee was frustrated that he wasn't making his mark.

CORRECTED-OBITUARY-Samsung's Lee: tainted titan who built a global tech giant

25 Oct 2020

SEOUL, Oct 25 In February 1993, five years after taking over from his father at South Korea's Samsung Group, 51-year-old Lee Kun-hee was frustrated that he wasn't making his mark.

In coronavirus vaccine race, China inoculates thousands before trials are completed

16 Sep 2020

SHANGHAI/SINGAPORE China is inoculating tens of thousands of its citizens with experimental coronavirus vaccines and attracting international interest in their development, despite expert concerns over the safety of drugs that have not completed standard testing.

A big obstacle: Where can CanSino test its vaccine abroad?

31 Jul 2020

BEIJING/SINGAPORE CanSino Biologics Inc , one of many companies worldwide trying to develop a coronavirus vaccine, needs to conduct late-stage trials overseas if it is to stay in the race, experts say, but it has yet to announce another country willing to help.

ANALYSIS-A big obstacle: Where can CanSino test its vaccine abroad?

31 Jul 2020

BEIJING/SINGAPORE, July 30 CanSino Biologics Inc , one of many companies worldwide trying to develop a coronavirus vaccine, needs to conduct late-stage trials overseas if it is to stay in the race, experts say, but it has yet to announce another country willing to help.

World News